Article

Hands With Erosive Osteoarthritis Have More Functional Impairment, Pain

Patients with erosive osteoarthritis have more functional impairment and significantly more pain in the hands than patients with controlled inflammatory arthritis and patients with nonerosive OA.

Patients with erosive osteoarthritis (OA) have more functional impairment and significantly more pain in the hands than patients with controlled inflammatory arthritis and patients with nonerosive OA. The main contributing factors are radiographic damage, number of tender joints, reduction in grip strength, and female sex.

Wittoek and colleagues studied 270 patients with hand OA and a group of patients with inflammatory arthritis (rheumatoid arthritis or psoriatic arthritis) who had low disease activity or disease in remission. Levels of functional impairment were measured by the Functional Index for Hand OA (FIHOA) and Australian/Canadian OA Hand Index (AUSCAN).

Patients with erosive OA had worse functional outcome and pain scores than patients with controlled inflammatory arthritis or nonerosive OA, even though a higher percentage of them were taking analgesics. After correction for potential confounders, pain scores remained significantly higher in patients with erosive OA. There was a trend in FIHOA and AUSCAN function scores toward more disability in patients with erosive OA. The presence of radiographic OA of the carpometacarpal joints did not influence functional outcome in the patients with erosive OA.

The authors noted that their study results highlight erosive OA's significant clinical burden and suggest a need for new treatment strategies.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.